The Duchenne muscular dystrophy community has had quite a ride for the last few months as several of its best hopes for gaining an approved treatment have been dashed by regulatory rejections. Now Marathon Pharmaceuticals LLC is entering the field seeking approval for its DMD treatment candidate.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?